Objective Mycoplasma pneumoniae is one of the major etiological agents causing respiratory infection worldwide in all age groups.Generally, M.pneumoniae infection is considered as a self-limiting disease with good prognosis.However, more and more severe and refractory M.pneumoniae pneumonia (MPP) cases have been reported in recent years, and some of them even developed life-threatening complications.